16 research outputs found
An overview of fuel retention and morphology in a castellated tungsten limiter
A castellated tungsten test limiter composed of detachable segments was exposed to plasma discharges in the TEXTOR to kamak operated with graphite main limiters. Dismantling of the limiter enabled the analysis Of Surfaces located inside the castellation, The emphasis was on the determination of: (i) deposition and fuel retention; (ii) material mixing and new Compound formation on plasma-facing Surfaces and in the grooves of castellation. The investigation performed by means of accelerator-based ion beam analysis methods, microscopy and X-ray diffraction has brought several essential results: (i) deuterium retention oil plasma-facing Surfaces and in the castellation of metal PFC is strongly related to the co-deposition with carbon; (ii) both carbon and deuterium are detected only in narrow belts, a few millimetre broad, clown the gap with the decay length of around 1.2-1.8 mm; (iii) the presence of copper droplets and tungsten oxide (WO2) has been identified in the gaps. Different pathways leading to the oxide formation are considered. (C) 2008 Elsevier B.V. All rights reserved
Examining the links between CSR and IHRM strategy : a comparative study of the UK AND Korea
EThOS - Electronic Theses Online ServiceGBUnited Kingdo
Plasma-induced damage of tungsten coatings on graphite limiters
Vaccum plasma sprayed tungsten coatings with an evaporated sandwich Re - W interlayer on graphite limiter blocks were studied after the experimental campaign in the TEXTOR tokamak. The coating morphology was modified by high-heat loads and co-deposition of species from the plasma. Co-deposits contained fuel species, carbon, boron and silicon. X-ray diffractometer phase analysis indicated the coexistence of metallic tungsten and its carbides (WC and W2C) and boride (W2B). In the Re - W layer the presence of carbon was detected in a several micrometres thick zone. In the overheated part of the limiter, the Re - W layer was transformed into a sigma phase